Oncology News | pharmaphorum

News

AI firm aims to revolutionise drug R&D with new UK facility

Artificial Intelligence company BenevolentAI has bought a drug discovery and development facility at the Babraham Research Campus in Cambridge for an undisclosed sum.

News

Immunotherapy arms race latest: Merck buys Viralytics for $3...

Big pharma pays 160% premium for Australian biotech

Digital

South Korea flag is waving at a beautiful and peaceful sky in day time while sun is shining. 3D Rendering

South Korea hopes big data will boost life sciences industry

South Korea is to build a comprehensive database of genetic and biometric data from 10 million people, in a bid to boost its pharma and biotech industry.

News

Groundbreaking lung cancer approval a big boost for AZ's Imf...

AstraZeneca’s immunotherapy Imfinzi has gained US approval in an important new earlier treatment setting for lung cancer patients.

News

Roche to buy health records firm Flatiron for $1.9bn

Flatiron has backers including Google parent Alphabet

News

J&J gets quick approval for new next-gen prostate cancer dru...

The FDA has approved Johnson & Johnson’s next generation prostate cancer drug, apalutamide in an early but tough to treat form of prostate cancer that has not spread.

AI firm aims to revolutionise drug R&D with new UK facility

Immunotherapy arms race latest: Merck buys Viralytics for $3...

South Korea hopes big data will boost life sciences industry

Groundbreaking lung cancer approval a big boost for AZ's Imf...

Roche to buy health records firm Flatiron for $1.9bn

J&J gets quick approval for new next-gen prostate cancer dru...

Moderna's Q1 revenues rocket, thanks to ex-US sales

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks